NDC 00054-0063-44: Risperidone 1 mg/mL Solution, 30 mL Bottle
This is a package of 30 mL of Risperidone 1 mg/mL Solution from Hikma Pharmaceuticals USA Inc., no longer marketed, no longer in the FDA NDC Directory; retail pharmacies pay about $0.2087 per mL (NADAC). It is this product's only package size.
NDC database record
One package, one record: these facts belong to NDC 0054-0063-44 alone.
- Record
- FDA NDC Directory package listing · Human prescription drug
- Code segments
- 0054 labeler · 0063 product · 44 package
- Billing quantity
- 30 mL per package
- Barcode (UPC-A, from the NDC)
- 3 0054006344 3
- FDA record last changed
- Mar 13, 2024
Identity & classification
Regulatory identifiers FDA, NLM and CMS codes for this package
Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification
- GSN (GCN sequence number): 026177
- GCN: 16135
- HICL (First Databank): 008721
- AHFS class code: 28:16.08.04
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
- RxNorm (NLM RxNav) · catalog refreshed Nov 19, 2026
- Medi-Span GPI (licensed)
- First Databank (licensed) · refreshed Nov 19, 2026
Clinical
Risperidone is used to treat schizophrenia (a mental illness that affects how a person thinks, feels and behaves), bipolar disorder (a disease that causes depression, mania, and other abnormal moods), and irritability symptoms (aggression, temper tantrums, mood changes) in those with autistic disorder (a developmental problem that affects how individuals communicate, learn and behave). Risperidone is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
Read the full MedlinePlus article ↗- It treats schizophrenia, manic or mixed episodes of bipolar I disorder, and irritability linked to autistic disorder in children. Which uses apply depends on the form. Injections l...
- Yes. Food doesn't change how well your body absorbs it, so you can take it with or without meals. Follow your prescriber's directions on timing.
- Common ones include sleepiness, dizziness, restlessness, stiffness or tremor, nausea, constipation, dry mouth, and weight gain. Call your doctor about uncontrolled movements, high...
- Be careful. Risperidone affects the brain and can cause sedation, and alcohol may add to that. Ask your pharmacist or prescriber what is safe for you.
Patient education
Drug interactions
Supplement & herbal interactions
Some supplements/herbs that may interact with Risperidone — tap one for details:
Where does this data come from?
- MedlinePlus (NLM) · refreshed Nov 19, 2026
- FDA label on DailyMed · label index refreshed Nov 21, 2026
Ask a licensed pharmacist directly — free, answered by our team.
Pricing
A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.
| Price system | Per mL | Per package |
|---|---|---|
| Retail pharmacies payNADAC · weekly | $0.209 | $6.26 / 30 ml |
| Medicaid paysCMS SDUD · 12 mo | No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data. | |
| Medicare drug plans payPart D · quarterly | No Part D plan price is available for this NDC in our data. | |
Where does this data come from?
- CMS NADAC weekly file · file of May 29, 2024
- CMS ASP pricing files · refreshed Nov 20, 2026
- CMS Medicaid State Drug Utilization Data · refreshed Nov 19, 2026
- CMS Part D plan pricing files · refreshed Oct 24, 2026
- VA National Acquisition Center price file
Packaging — all sizes for this product
| Package NDC | Description | Marketing start | Marketing end | Status |
|---|---|---|---|---|
| 00054-0063-44 You're viewing this Main listing | 30 mL in 1 BOTTLE | 2009-07-29 | — | Discontinued by firm |
Therapeutic equivalents
| Product | Labeler | Pack | NADAC/unit | TE | Status | Price vs. this |
|---|---|---|---|---|---|---|
| Risperidone 1 mg/mLthis 00054-0063-44 | Hikma | 30 ml | $0.209 | — | Discontinued | — |
| Risperidone 1 mg/mL 27808-0002-01 | Cranbury | 30 ml | $0.470 | AA | Availability likely | +125% |
| Risperidone 1 mg/mL 50458-0596-01 | Janssen | 30 ml | $0.470 | AA | Availability likely | +125% |
| Risperidone 1 mg/mL 62135-0929-43 | Chartwell | 30 ml | $0.470 | AA | Availability likely | +125% |
| Risperidone 1 mg/mL 62559-0981-30 | ANI | 30 ml | $0.470 | AA | Availability likely | +125% |
| Risperidone 1 mg/mL 65162-0673-84 | Amneal | 30 ml | $0.470 | AA | Availability likely | +125% |
| Risperdal 1 mg/mL 50458-0305-03 | Janssen | 30 ml | $5.277 | AA | Availability likely | +2428% |
| Risperidone 1 mg/mL 17856-1002-01 | ATLANTIC | 120 syringes | — | AA | FDA listed | — |
| Risperidone 1 mg/mL 65862-0167-01 | Aurobindo | 1 bottle | — | AA | FDA listed | — |
| Risperidone 1 mg/mL 70518-3741-00 | REMEDYREPACK | 10 cups | — | AA | FDA listed | — |
| Risperidone 1 mg/mL 70518-3760-00 | REMEDYREPACK | 10 cups | — | AA | FDA listed | — |
| Risperidone 1 mg/mL 71335-2733-01 | Bryant | 30 ml | — | AA | FDA listed | — |
| Risperidone 1 mg/mL 72162-2037-03 | Bryant | 30 ml | — | AA | FDA listed | — |
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- FDA Orange Book · refreshed Nov 6, 2026
- CMS NADAC weekly file · file of May 29, 2024
Availability & generic status
This product is an FDA-approved generic. Other versions of the same drug are listed under Therapeutic equivalents, least expensive first.
Where does this data come from?
- FDA Orange Book · refreshed Nov 6, 2026
Inactive Ingredients / Excipients
Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.
🧪 Avoiding an ingredient? See Risperidone inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.
Where does this data come from?
IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.- FDA label on DailyMed · label index refreshed Nov 21, 2026
- FDA openFDA NDC Directory · synced Nov 19, 2026
Inactive ingredient FAQ
Are inactive ingredients the same for every manufacturer?
Why might an inactive ingredient be missing?
Can inactive ingredients matter?
Manufacturer & labeler
More NDCs from Hikma Pharmaceuticals USA Inc. labeler code 00054
- Lithium Carbonate 450 mg Tablet, Extended Release NDC 0054-0020-25
- Lithium Carbonate 300 mg Tablet, Extended Release NDC 0054-0021-25
- Ipratropium Bromide 21 ug Spray NDC 0054-0045-44
- Ipratropium Bromide 42 ug Spray NDC 0054-0046-41
- Digoxin .05 mg/mL Solution NDC 0054-0057-46
- Citalopram 10 mg/5mL Solution NDC 0054-0062-58
- Ondansetron Hydrochloride 4 mg/5mL Solution NDC 0054-0064-47
- Torsemide 20 mg Tablet NDC 0054-0077-25
- Balsalazide Disodium 750 mg Capsule NDC 0054-0079-28
- Zaleplon 5 mg Capsule NDC 0054-0084-25
- Zaleplon 10 mg Capsule NDC 0054-0085-25
- Calcium Acetate 667 mg Capsule NDC 0054-0088-13
Where does this data come from?
- FDA openFDA NDC Directory · synced Nov 19, 2026
- Drugs@FDA
Full prescribing information FDA SPL
📄 FDA label ▾
No FDA label is on file for this product yet. Labels load from openFDA / DailyMed and refresh weekly.
Medicare Part D spend CMS · PART D · 2026 (Q1)
Reported adverse events (FAERS)
Top reported reactions
Age at onset
Reporter sex
Serious outcomes
Where does this data come from?
About this NDC listing & data coverage
What data is (and isn’t) available for this NDC — tap to expand
| NDC identity (package / product / labeler codes) | ✓ Available |
| Labeler | ✓ Available |
| Product & package description | ✓ Available |
| Marketing category & status | ✓ Available |
| Active ingredient / dosage form / route | ✓ Available |
| FDA label (SPL via DailyMed) | — Not published for this NDC No structured label is linked to this listing in DailyMed/openFDA. |
| Package photos | — Not published for this NDC No photo available yet for this listing. |
| Inactive ingredients (structured) | — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available. |
| NADAC pharmacy acquisition price (CMS) | ✓ Available |
| Orange Book / therapeutic-equivalence data | — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope. |
| HCPCS J-code billing crosswalk | — Not published for this NDC Most self-administered / retail products have no J-code — that is normal. |
| Medicaid utilization (CMS SDUD) | — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold. |